CIK: 0001512848 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $1,328,451 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 3,745,262 | $246,626 | 18.6% | $16.54 | +276.3% | COMMON STOCK | 03940C100 |
| — | VERONA PHARMA PLC | 2,263,138 | $214,048 | 16.1% | $8.67 | — | SPONSERED ADS | 925050106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,909,956 | $183,880 | 13.8% | $26.40 | +131.9% | COM | 76243J105 |
| COUR | COURSERA INC | 12,867,769 | $112,722 | 8.5% | $45.00 | -81.8% | COM | 22266M104 |
| CRSP | CRISPR THERAPEUTICS AG | 1,587,854 | $77,233 | 5.8% | $20.40 | +89.7% | NAMEN AKT | H17182108 |
| TRVI | TREVI THERAPEUTICS INC | 13,222,228 | $72,326 | 5.4% | $2.98 | +108.4% | COM | 89532M101 |
| SVRA | SAVARA INC | 24,471,264 | $55,794 | 4.2% | $1.74 | +56.6% | COM | 805111101 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,118,621 | $41,804 | 3.1% | $8.94 | -24.9% | COM | 68622P109 |
| MBX | MBX BIOSCIENCES INC | 3,614,486 | $41,241 | 3.1% | $22.87 | -55.5% | COM | 55287L101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 7,692,298 | $34,692 | 2.6% | $20.37 | -78.1% | COM | 61225M102 |
| AUPH | AURINIA PHARMACEUTICALS INC | 3,969,834 | $33,624 | 2.5% | $6.46 | +24.1% | COM | 05156V102 |
| CELC | CELCUITY INC | 2,294,261 | $30,628 | 2.3% | $10.53 | +3.4% | COM | 15102K100 |
| ZBIO | ZENAS BIOPHARMA INC | 2,733,719 | $26,490 | 2.0% | $17.62 | -44.7% | COM | 98937L105 |
| GOSS | GOSSAMER BIO INC | 18,093,034 | $22,254 | 1.7% | $3.27 | -66.7% | COM | 38341P102 |
| — | NEUEHEALTH INC | 2,726,917 | $18,816 | 1.4% | $12.22 | — | COM NEW | 10920V404 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,960,169 | $18,798 | 1.4% | $10.51 | -47.4% | COM | 71722W107 |
| KRRO | KORRO BIO INC | 1,090,793 | $13,624 | 1.0% | $33.32 | -56.8% | COM | 500946108 |
| CSBR | CHAMPIONS ONCOLOGY INC | 1,713,720 | $12,630 | 1.0% | $6.16 | +14.5% | COM NEW | 15870P307 |
| CVRX | CVRX INC | 2,026,083 | $11,913 | 0.9% | $28.00 | -75.4% | COM | 126638105 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 4,448,757 | $11,033 | 0.8% | $23.88 | -91.9% | COM | 09203E105 |
| — | INOZYME PHARMA INC | 2,437,689 | $9,751 | 0.7% | $26.29 | — | COM | 45790W108 |
| SNTI | SENTI BIOSCIENCES INC | 3,775,615 | $7,967 | 0.6% | $3.75 | -15.5% | COM NEW | 81726A209 |
| OMDA | OMADA HEALTH INC | 364,115 | $6,663 | 0.5% | $17.31 | 0.0% | COM | 68170A108 |
| NKTX | NKARTA INC | 3,568,781 | $5,924 | 0.4% | $26.42 | -93.1% | COM | 65487U108 |
| IVA | INVENTIVA SA | 1,462,586 | $4,666 | 0.4% | $7.21 | — | ADS | 46124U107 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 17,079,778 | $4,094 | 0.3% | $8.44 | — | SPONDS ADR | 00653A107 |
| SYBX | SYNLOGIC INC | 2,922,772 | $3,712 | 0.3% | $2.94 | -60.8% | COM NEW | 87166L209 |
| MRKR | MARKER THERAPEUTICS INC | 1,625,678 | $2,487 | 0.2% | $2.77 | -53.7% | COM NEW | 57055L206 |
| OKUR | ONKURE THERAPEUTICS INC | 478,548 | $1,144 | 0.1% | $15.14 | -82.7% | COM CL A | 68277Q105 |
| — | X4 PHARMACEUTICALS INC | 499,559 | $949 | 0.1% | $1.51 | — | COM | 98420X103 |
| — | IKENA ONCOLOGY INC | 600,063 | $804 | 0.1% | $2.54 | — | COM | 45175G108 |
| UP | WHEELS UP EXPERIENCE INC | 106,125 | $114 | 0.0% | $3.53 | -65.2% | COM CL A | 96328L205 |